2-109129609-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001099289.3(SH3RF3):c.69C>A(p.Asp23Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001099289.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SH3RF3 | NM_001099289.3 | c.69C>A | p.Asp23Glu | missense_variant | 1/10 | ENST00000309415.8 | NP_001092759.1 | |
SH3RF3 | XM_011511109.3 | c.69C>A | p.Asp23Glu | missense_variant | 1/9 | XP_011509411.1 | ||
RANBP2 | XM_047445367.1 | c.8370+356563C>A | intron_variant | XP_047301323.1 | ||||
SH3RF3-AS1 | NR_029193.1 | n.511G>T | non_coding_transcript_exon_variant | 1/1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SH3RF3 | ENST00000309415.8 | c.69C>A | p.Asp23Glu | missense_variant | 1/10 | 5 | NM_001099289.3 | ENSP00000309186.6 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1328932Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 654606
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 04, 2024 | The c.69C>A (p.D23E) alteration is located in exon (coding exon ) of the SH3RF3 gene. This alteration results from a C to A substitution at nucleotide position 69, causing the aspartic acid (D) at amino acid position 23 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.